{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:19:44Z","timestamp":1790983184124,"version":"4.1.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,30]]},"DOI":"10.7759\/cureus.113668","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:58:56Z","timestamp":1785423536000},"source":"Crossref","is-referenced-by-count":1,"title":["Unrecognized Charcot-Marie-Tooth Disease Unmasked by Chemotherapy-Induced Neurotoxicity"],"prefix":"10.7759","author":[{"given":"Isabel V","family":"Fernandes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela M","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Isabel","family":"Pazos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udia","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2014.09.020","article-title":"Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis","volume":"155","author":"Seretny M","year":"2014","unstructured":"Seretny M, Currie GL, Sena ES, et al.. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain. 2014, 155:2461-70. 10.1016\/j.pain.2014.09.020","journal-title":"Pain"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2017.00174","article-title":"Pathophysiology of chemotherapy-induced peripheral neuropathy","volume":"10","author":"Starobova H","year":"2017","unstructured":"Starobova H, Vetter I. Pathophysiology of chemotherapy-induced peripheral neuropathy. Front Mol Neurosci. 2017, 10:174. 10.3389\/fnmol.2017.00174","journal-title":"Front Mol Neurosci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01399","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update","volume":"38","author":"Loprinzi CL","year":"2020","unstructured":"Loprinzi CL, Lacchetti C, Bleeker J, et al.. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update. J Clin Oncol. 2020, 38:3325-48. 10.1200\/JCO.20.01399","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-9-38","article-title":"PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and hereditary heuropathy with liability to pressure palsies","volume":"9","author":"van Paassen BW","year":"2014","unstructured":"van Paassen BW, van der Kooi AJ, van Spaendonck-Zwarts KY, Verhamme C, Baas F, de Visser M. PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and hereditary heuropathy with liability to pressure palsies. Orphanet J Rare Dis. 2014, 9:38. 10.1186\/1750-1172-9-38","journal-title":"Orphanet J Rare Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2013.179","article-title":"Clinical implications of genetic advances in Charcot-Marie-Tooth disease","volume":"9","author":"Rossor AM","year":"2013","unstructured":"Rossor AM, Polke JM, Houlden H, Reilly MM. Clinical implications of genetic advances in Charcot-Marie-Tooth disease. Nat Rev Neurol. 2013, 9:562-71. 10.1038\/nrneurol.2013.179","journal-title":"Nat Rev Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/jns.12566","article-title":"Toxic medications in Charcot-Marie-Tooth patients: a systematic review","volume":"28","author":"Cavaletti G","year":"2023","unstructured":"Cavaletti G, Forsey K, Alberti P. Toxic medications in Charcot-Marie-Tooth patients: a systematic review. J Peripher Nerv Syst. 2023, 28:295-307. 10.1111\/jns.12566","journal-title":"J Peripher Nerv Syst"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2017.1415462","article-title":"Antineoplastic agents exacerbating Charcot Marie Tooth disease: red flags to avoid permanent disability","volume":"57","author":"Iba\u00f1ez-Juli\u00e1 MJ","year":"2018","unstructured":"Iba\u00f1ez-Juli\u00e1 MJ, Berzero G, Reyes-Botero G, et al.. Antineoplastic agents exacerbating Charcot Marie Tooth disease: red flags to avoid permanent disability. Acta Oncol. 2018, 57:403-11. 10.1080\/0284186X.2017.1415462","journal-title":"Acta Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21388","article-title":"The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging","volume":"67","author":"Amin MB","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, et al.. The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging. CA Cancer J Clin. 2017, 67:93-9. 10.3322\/caac.21388","journal-title":"CA Cancer J Clin"},{"key":"ref9","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken MM","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982, 5:649-55.","journal-title":"Am J Clin Oncol"},{"key":"ref10","unstructured":"US Department of Health and Human Services, National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. (2017). Accessed: July 7, 2026: https:\/\/dctd.cancer.gov\/research\/ctep-trials\/for-sites\/adverse-events\/ctcae-v5-5x7.pdf."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000001236","article-title":"Neurologic complications of cancer treatment","volume":"29","author":"Porter AB","year":"2023","unstructured":"Porter AB. Neurologic complications of cancer treatment. Continuum (Minneap Minn). 2023, 29:903-22. 10.1212\/CON.0000000000001236","journal-title":"Continuum (Minneap Minn)"},{"key":"ref12","article-title":"Severe vincristine neuropathy in Charcot-Marie-Tooth disease type 1A","volume":"77","author":"Graf WD","year":"1996","unstructured":"Graf WD, Chance PF, Lensch MW, Eng LJ, Lipe HP, Bird TD. Severe vincristine neuropathy in Charcot-Marie-Tooth disease type 1A. Cancer. 1996, 77:1356-62.","journal-title":"Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2005.01.017","article-title":"The administration of chemotherapy in a patient with Charcot-Marie-Tooth and ovarian cancer","volume":"97","author":"Martino MA","year":"2005","unstructured":"Martino MA, Miller E, Grendys EC Jr. The administration of chemotherapy in a patient with Charcot-Marie-Tooth and ovarian cancer. Gynecol Oncol. 2005, 97:710-2. 10.1016\/j.ygyno.2005.01.017","journal-title":"Gynecol Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v8.i5.425","article-title":"Charcot-Marie-Tooth hereditary neuropathy revealed after administration of docetaxel in advanced breast cancer","volume":"8","author":"Kourie HR","year":"2017","unstructured":"Kourie HR, Mavroudakis N, Aftimos P, Piccart M. Charcot-Marie-Tooth hereditary neuropathy revealed after administration of docetaxel in advanced breast cancer. World J Clin Oncol. 2017, 8:425-8. 10.5306\/wjco.v8.i5.425","journal-title":"World J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/516881-unrecognized-charcot-marie-tooth-disease-unmasked-by-chemotherapy-induced-neurotoxicity","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:58:57Z","timestamp":1785423537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/516881-unrecognized-charcot-marie-tooth-disease-unmasked-by-chemotherapy-induced-neurotoxicity"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.113668","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,30]]}}}